CSJA:FRA
CSL ADR
29,00 €
arrow_upward
+1,40%(+0,40) 1D
20-ноя., 22:00:00 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSJA...
Open
28,40 €
High
29,00 €
Low
28,40 €
Mkt. cap
94,68 млд
Avg. vol.
1,00
Volume
0,00
52-wk high
43,40 €
52-wk low
12,70 €
No. of employees
29 миң
Open
28,40 €
High
29,00 €
Low
28,40 €
Mkt. cap
94,68 млд
Avg. vol.
1,00
Volume
0,00
52-wk high
43,40 €
52-wk low
12,70 €
No. of employees
29 миң
News stories
From web sources and news partners
Kalkine
·
4 саат мурун
What Do the FY26 Impairments at CSL (ASX:CSL) Add to Its Weekly Share Update?
ad-hoc-news.de
·
7 саат мурун
CSL stock: Evans and Partners cuts rating to Neutral
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees29 миң
Founded1916
HeadquartersМельбурн, Виктория, Австралия
SectorHealth Care
Industry-
Websitecsl.com